Home Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research
 

Keywords :   


Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research

2016-01-25 01:16:11| Biotech - Topix.net

The firm presently has a $2.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's target price indicates a potential upside of 4.04% from the stock's current price.

Tags: buy research investment upgraded

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
More »